Table 1 Patient and tumor characteristics.
N (%) | NCT group (n = 64) | NET group (n = 59) | p |
|---|---|---|---|
Mean age ± SD (in years) | 41.80 \(\pm \) 5.34 | 41.97 \(\pm \) 6.19 | 0.877 |
BMI | |||
Underweight | 4 (6.3) | 3 (5.1) | 0.376 |
Normal weight | 43 (67.2) | 42 (71.2) | |
Overweight | 16 (25) | 10 (16.9) | |
Obese | 1 (1.6) | 4 (6.8) | |
HTN* | |||
Normal + elevated | 48 (78.7) | 35 (61.4) | 0.040 |
HTN | 13 (21.3) | 22 (38.6) | |
Initial mean tumor size ± SD (in cm) | |||
USG | 3.27 \(\pm 1.81\) | 3.57 \(\pm 1.80\) | 0.263 |
MRI | 3.46 \(\pm \) 1.79 | 4.16 \(\pm \) 1.85 | 0.026 |
T stage by USG | |||
T1 | 18 (28.1) | 11 (18.6) | 0.425 |
T2 | 38 (59.4) | 38 (64.4) | |
T3 | 8 (12.5) | 10 (17.0) | |
T4 | 0 (0) | 0 (0) | |
Nodal status | |||
N1–2 | 60 (93.8) | 56 (94.9) | 1 |
N3 | 4 (6.2) | 3 (5.1) | |
Histologic grade | |||
1–2 | 56 (87.5) | 56 (94.9) | 0.150 |
3 | 8 (12.5) | 3 (5.1) | |
ER receptor status N (%) | |||
5–6 | 5 (7.8) | 3 (5.1) | 0.719 |
7–8 | 59 (92.2) | 56 (95) | |
PR receptor status | |||
0–2 | 8 (12.5) | 8 (13.6) | 0.736 |
3–6 | 18 (28.1) | 20 (33.8) | |
7–8 | 38 (59.4) | 31 (52.5) | |
